I. Micallef

Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma

S. Ansell, S. Markovic, D. Gastineau, 2006, Bone Marrow Transplantation.

Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma

S. Ansell, S. Markovic, D. Gastineau, 2004, Bone Marrow Transplantation.

Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.

D. Dingli, S. Ansell, A. Dispenzieri, 2013, Bone Marrow Transplantation.

Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I study

T. Habermann, S. Ansell, C. Reeder, 2011, Leukemia.

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

T. Habermann, M. Gupta, S. Ansell, 2010, Leukemia.

Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma

T. Habermann, S. Ansell, S. Markovic, 2012, Blood Cancer Journal.